A CDC survey shows that overall screening rates for colorectal cancer increased between 2002 and 2006, but the rates vary considerably among states and are still lower among certain minority groups and those without health insurance. Medscape Medical News
A population-based study found better survival for localized prostate cancer patients who received curative therapy than for those who underwent watchful waiting. Medscape Medical News
Is there a new role for EGFR inhibitors in the treatment of lung cancer? In this expert column, Dr. Neil and Dr. Heist review the latest data. Medscape Hematology-Oncology
Results from the QUASAR trial show that adjuvant chemotherapy with fluorouracil improves survival in patients with stage 2 colorectal cancer, although the benefit is small. Medscape Medical News
In this Special Report, expert hematologists address the pros and cons of current therapies for myelodysplastic syndrome-related thrombocytopenia and detail promising investigational approaches. Medscape Hematology-Oncology
